Banerji, U., van Herpen, C. M. L., Saura, C., Thistiethwaite, F., Lord, S., Moreno Aguado, V., . . . Aftimos, P. (2019). Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: A phase 1 dose-escalation and dose-expansion study.
Citación estilo ChicagoBanerji, Udai, et al. Trastuzumab Duocarmazine in Locally Advanced and Metastatic Solid Tumours and HER2-expressing Breast Cancer: A Phase 1 Dose-escalation and Dose-expansion Study. 2019.
Cita MLABanerji, Udai, et al. Trastuzumab Duocarmazine in Locally Advanced and Metastatic Solid Tumours and HER2-expressing Breast Cancer: A Phase 1 Dose-escalation and Dose-expansion Study. 2019.
Precaución: Estas citas no son 100% exactas.